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  The  prevalence  of  feline  herpesvirus-1  (FHV-1),  feline 
calicivirus (FCV), and Chlamydophila (C.) felis was stud-
ied in cats of an animal shelter in Korea. Total 78 cats 
without ocular and upper respiratory tract disease were 
examined.  Specimens  were  obtained  from  ocular  con-
junctiva  and  oropharynx.  Using  multiplex  polymerase 
chain  reaction  (PCR)  and  reverse  transcription  PCR, 
three pathogens were simultaneously detected. In exam-
ined  78  cats,  49  (63%)  cats  were  positive  for  FHV-1. 
However,  all  specimens  were  negative  for  C.  felis  and 
FCV. In conclusion, many cats recovered from FHV-1 in-
fection remain subclinical carriers in shelter environment.
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  Feline herpesvirus type 1 (FHV-1) is the most frequent 
cause of conjunctivitis, and it also induces corneal ulcers, 
stromal keratitis, corneal sequestration and keratocon-
junctivitis sicca in cats [14]. Chlamydophila  (C.)  felis 
(previously called Chlamydia psittaci) is another major 
conjunctival pathogen [13]. Feline calicivirus (FCV) is an 
unlikely and minor primary conjunctival pathogen [9]. It is 
considered to be the most common upper respiratory tract 
disease (URTD) associated pathogen in cats [16].
  The prevalence of FHV-1, FCV and C. felis in cats through-
out the world has been frequently reported [1-3,5,6,12, 
15,16]. However, there have been relatively fewer of these 
studies for clinically normal cats in a shelter environment 
[1,5,11] and no such research has been done in Korea. The 
purpose of this study is to identify the prevalence of 
FHV-1, FCV and C. felis in clinically normal cats of a 
Korean animal shelter by performing multiplex reverse 
transcription-polymerase chain reaction (RT-PCR)/PCR.
  Samples were collected from one animal shelter (Yangju, 
Korea) during January 2005. The animals were held at least 
30 days and euthanasia was performed because of illness or 
injury, or insufficient available space. The shelter was 
traditional with no quarantine for incoming cats, but the 
cats having diseases were separated from the main shelter. 
  A total of 78 cats were examined before they underwent 
euthanasia. Based on their history and ophthalmic (using 
slit lamp biomicroscopy) and physical examinations, they 
had clinically normal eyes and they had no specific clinical 
signs of URTD. All the cats were domestic short-haired or 
long-haired. The number of male cats examined was 40 
and 38 were females. The cats’ age and neuter and vaccina-
tion status could not be exactly determined. For each cat, 
specimens were obtained using three sterile cotton tipped 
swabs in the conjunctival sac of both eyes and the oropha-
rynx, respectively. These were preserved in 2 ml phosphate 
buffered saline (PBS, 0.01 M NaPO4, pH 7.0) and they 
were immediately sent to the laboratory within 2 h and then 
stored at 򰠏70
oC until they were assayed. Before the sub-
sequent nucleic acid extraction, the specimens that were 
separately obtained from the three sites were thoroughly 
mixed.
  One commercial vaccine (Felocell CVR-C; Pfizer Ani-
mal Health, USA) was used as a positive control. It was the 
only licensed vaccine for preventing FHV-1, FCV and C. 
felis in Korea at the time of the study. Sterile distilled water 
without nucleic acids was used as a negative control. Both 
the controls were subjected to nucleic acid extraction and 
PCR. The nucleic acids were extracted from specimens by 
using the Viral Gene-spin kit (Intron Biotechnology, 
Korea) according to the manufacturer’s instructions. 
  Three pairs of oligonucleotide primers were used for the 
amplifying reaction. We used the previous designed primer 
sequences by Sykes et al. [16]. HerpF (5'-GACGTGGT 
GAATTATCAGC-3') and HerpR (5'-CAACTAGATTT 
CCACCAGGA-3') amplify a 292-base pair (bp) region in 
the thymidine kinase (TK) gene of FHV-1.  ChlaF (5'- 
ATGAAAAAACTCTTGAAATCGG-3') and ChlaR (5'- 
CAAGATTTTCTAGACTTCATTTTGTT-3') amplify a 
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Fig. 1.  Multiplex RT-PCR/PCR amplication of FHV-1, C. felis
and FCV from the specimens (S1 and S2) collected from two 
cats. Molecular size standard markers (M) are shown as base 
pairs (bp) on the left for comparison. The positive control (P) ex-
tracted from commercial vaccine strains shows three bands, and
their sizes are 292 bp (for FHV), 673 bp (for FCV) and 1069 bp 
(for C. felis). S1 and S2 show positive reactions for FHV-1, and
they are negative for FCV and C. felis. The negative control (N)
is shown on the right.
C. felis. CalcapF (5'-TTCGGCCTTTTGTGTTCC-3') and 
CalcapR (5'-TTGAGAATTGAACACATCAATAGATC-3') 
amplify a 673-bp conserved region in the capsid protein 
gene of FCV. 
  Multiplex RT-PCR/PCR was performed according to a 
previous study [16]. Each 15 μl of reaction products was 
electrophoresed through a 1.5% agarose gel and the 
proteins were stained with ethidium bromide; the appro-
priate molecular weight markers (100-bp DNA ladder; 
Bioneer, Korea) are adjacent to them. The positive control 
included the extracted nucleic acid of the commercial 
strains in the vaccine and the negative control consisted of 
all the RT-PCR/PCR reagents except the nucleic acid; 
these were included in each reaction. 
  When 78 clinically normal cats were examined, 49 (63%) 
were positive for FHV-1. Of the 40 male cats examined, 
FHV-1 was detected in 23 cats (58%) and 26 of the 38 
female cats (68%) were positive to FHV-1. However, C. 
felis and FCV were negative in all the specimens we 
obtained. The products resulting from amplification of 
FHV-1, C. felis and FCV in two specimens are shown in 
Fig. 1.
  Many studies have reported on the prevalence of FHV-1, 
C. felis and FCV in clinically normal or abnormal cats 
[1-3,5,6,8,12,15,16]. There were various detection rates of 
FHV-1 according to the breeding sites, the countries and 
the cats’ clinical status. The prevalence of FHV-1 was 
ranged from 0 to 52% for clinically normal cats of a 
breeding cattery or shelter in Sweden [6], the USA [2, 
11,15] and European countries [5]. The prevalence of 
FHV-1 for client-owned normal cats was 5.9% [10] and 
this was 12% [15] in the USA. The percentage of cats with 
diseases at a breeding cattery or shelter in European 
countries [5] and the USA [1] ranged from 0 to 41%. For 
client-owned abnormal cats, FHV-1 was detected in 4.5% 
to 76.3% of the cats in Japan [3,9], the USA [2,3,10,15], 
Australia [16] and Italy [12]. Based on these findings, the 
FHV-1 positive rates of the shelter cats were generally 
higher than those of the client owned-cats or the breeding 
cattery cats. Especially, many shelter cats without diseases 
had a higher prevalence than did the clinically abnormal 
client-owned cats. We think that the results are due to that 
many shelter cats have been infected with FHV-1 and they 
remain subclinical carriers after recovery. At least 80% of 
infected cats remain latently infected and 29% of them 
shed virus spontaneously [4]. Thus, FHV-1 has been 
frequently detected in latently infected cats that are without 
clinical signs. Also, those cats that live in a colony like an 
animal shelter, an animal hospital and a multi-cat house-
hold can be more frequently exposed to FHV-1.
  Among the shelter cats around the world, those in Korea 
have the highest prevalence of FHV-1 (63%). This result 
may be due to some reasons. The first is the difference in 
the frequency and level of stressful events that cats are 
exposed to in an animal shelter. Stress as simple as moving 
a cat into a new environment can convert a latent infection 
to an active infection in a few days [11]. Virus shedding 
continues for 1-2 weeks around 1 week after a stressful 
event [6]. Thus, in this study, cats may have the greatest 
risk of infection through more exposure to reactivated 
virus from carriers because the Korean housing enviro-
nment may be more stressful than that in other countries. 
The second reason is there is a high shedding rate for 
incoming cats at the time of first entry to the shelter. 
However, in other study, the shedding rate was much lower 
than the rate after 1 week in the shelter [11]. To certify this 
possibility, it will be necessary to investigate the pro-
portion of cats that already shed FHV-1 at the time they are 
relinquished.
  It was previously reported that the prevalence of C. felis in 
clinically normal cats of a breeding cattery or shelter was 
only 3% in European countries [5]. For cats with diseases 
and that are in the same environment, the prevalence of C. 
felis ranged from 0 to 10% in the USA [1] and European 
countries [5], whereas that of client owned abnormal cats 
was 11.5%, 20% and 59.1% in Australia [16], Italy [12] 
and Japan [3], respectively. According to these previous 
reports, clinically normal cats had a much lower pre-
valence of C. felis than that of abnormal cats. Unlike 
FHV-1, those cats in a shelter or a breeding cattery had a 
low detection rate of C. felis. These results indicate that the Prevalence of FHV-1, FCV and C. felis in an animal shelter    209
clinical signs of URTD or ocular disease are correlated 
with infection of C. felis and they are not related to the 
housing environment. C. felis was not detected in our 
study.
    Generally, normal cats without disease have a lower 
detection rate of FCV, ranging from 1 to 29% [5,8,9,11], 
than abnormal cats, ranging from 0 to 47% [1,3,5,9,16]. 
FCV was rarely detected in two studies that focused on 
clinically normal cats (1% in Japan and 2.6% in Sweden) 
[6,9]. One previous study even showed that FCV was not 
detected from clinically abnormal cats in some shelters [1]. 
In our present study, FCV was not detected at all. This 
result may be due to several reasons. First is a possibility 
that all the examined cats were not truly infected with FCV. 
The second possible reason is that the chronic infected cats 
were not shedding virus. Last, it has been reported that the 
lower detection rate of FCV is due to some problems for 
detecting virus on in the feline mucosal swabs, that is, the 
very small number of virus particles, the presence of 
RNase in the mucosa and the FCV’s genetic variability 
[16]. We can not exactly determine how these factors 
contribute to a low detection rate.
  This study demonstrated that many cats of an animal 
shelter in Korea, as well as other countries, remain latently 
infected with FHV-1. These cats would be sources of 
infection after returning to society. Thus, proper manage-
ment by veterinarians, cleaning protocols, a low stress 
environment and proper cage design are necessary in an 
animal shelter. Especially, it may be important to make a 
less stressful environment through decreasing the extent of 
crowding. Although vaccination with FHV-1 and FCV 
cannot lead to prevention of infection and viral shedding, 
this may reduce the overall severity of disease [16]. Thus, 
it is necessary to routinely vaccinate the individual shelter 
cats and to keep incoming cats from infected sources such 
as shelters and breeding catteries. 
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